High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer

Detalles Bibliográficos
Autores principales: Ghamande, Sharad, Mauro, David, Price, Cheryl, Wheatley, Donna, Janik, John, Khleif, Samir N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646097/
http://dx.doi.org/10.1186/2051-1426-3-S2-P151
_version_ 1782400913706582016
author Ghamande, Sharad
Mauro, David
Price, Cheryl
Wheatley, Donna
Janik, John
Khleif, Samir N
author_facet Ghamande, Sharad
Mauro, David
Price, Cheryl
Wheatley, Donna
Janik, John
Khleif, Samir N
author_sort Ghamande, Sharad
collection PubMed
description
format Online
Article
Text
id pubmed-4646097
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46460972015-11-20 High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer Ghamande, Sharad Mauro, David Price, Cheryl Wheatley, Donna Janik, John Khleif, Samir N J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646097/ http://dx.doi.org/10.1186/2051-1426-3-S2-P151 Text en Copyright © 2015 Ghamande et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Ghamande, Sharad
Mauro, David
Price, Cheryl
Wheatley, Donna
Janik, John
Khleif, Samir N
High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
title High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
title_full High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
title_fullStr High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
title_full_unstemmed High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
title_short High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
title_sort high-dose treatment with adxs11-001, a listeria monocytogenes (lm)-listeriolysin o (llo) immunotherapy, in women with cervical cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646097/
http://dx.doi.org/10.1186/2051-1426-3-S2-P151
work_keys_str_mv AT ghamandesharad highdosetreatmentwithadxs11001alisteriamonocytogeneslmlisteriolysinolloimmunotherapyinwomenwithcervicalcancer
AT maurodavid highdosetreatmentwithadxs11001alisteriamonocytogeneslmlisteriolysinolloimmunotherapyinwomenwithcervicalcancer
AT pricecheryl highdosetreatmentwithadxs11001alisteriamonocytogeneslmlisteriolysinolloimmunotherapyinwomenwithcervicalcancer
AT wheatleydonna highdosetreatmentwithadxs11001alisteriamonocytogeneslmlisteriolysinolloimmunotherapyinwomenwithcervicalcancer
AT janikjohn highdosetreatmentwithadxs11001alisteriamonocytogeneslmlisteriolysinolloimmunotherapyinwomenwithcervicalcancer
AT khleifsamirn highdosetreatmentwithadxs11001alisteriamonocytogeneslmlisteriolysinolloimmunotherapyinwomenwithcervicalcancer

Ejemplares similares